| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.08e-08 | 114 | 75 | 8 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 2.10e-08 | 124 | 75 | 8 | GO:0101005 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 4.23e-08 | 192 | 75 | 9 | GO:0008234 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 4.58e-08 | 137 | 75 | 8 | GO:0019783 | |
| GeneOntologyMolecularFunction | peptidase activity | USP50 USP10 USP9X USP40 USP7 PAPPA AGBL5 USP9Y USP48 ADAM10 PCSK4 ADAM22 USP19 CAPN11 | 1.26e-07 | 654 | 75 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.79e-05 | 86 | 75 | 5 | GO:0004197 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 3.27e-05 | 430 | 75 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine-6-sulfatase activity | 4.17e-05 | 3 | 75 | 2 | GO:0008449 | |
| GeneOntologyMolecularFunction | integrin binding | 5.08e-05 | 175 | 75 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 6.45e-05 | 21 | 75 | 3 | GO:1990380 | |
| GeneOntologyMolecularFunction | calcium ion binding | PITPNM1 FAT1 SULF2 MEGF8 SULF1 MAN1C1 PON1 PCDHA10 SCIN SVEP1 CAPN11 | 1.05e-04 | 749 | 75 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.06e-04 | 35 | 75 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 4.93e-04 | 9 | 75 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 8.97e-04 | 12 | 75 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | arylsulfatase activity | 1.23e-03 | 14 | 75 | 2 | GO:0004065 | |
| GeneOntologyMolecularFunction | glucosidase activity | 1.42e-03 | 15 | 75 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | sulfuric ester hydrolase activity | 1.83e-03 | 17 | 75 | 2 | GO:0008484 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.64e-03 | 153 | 75 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.72e-03 | 74 | 75 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | collagen binding | 3.52e-03 | 81 | 75 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | SMAD binding | 4.17e-03 | 86 | 75 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.57e-03 | 288 | 75 | 5 | GO:0016757 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 1.74e-08 | 125 | 75 | 8 | GO:0016579 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 5.28e-08 | 144 | 75 | 8 | GO:0070646 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | GALK1 MALRD1 BTD UGT2A1 ETFDH AKR1D1 UGT2A2 PON1 UGT2B10 DAO P4HA3 AASDH SCD5 TNXB PTGS2 ERLIN1 | 7.52e-07 | 1035 | 75 | 16 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | GALK1 MALRD1 BTD UGT2A1 ETFDH AKR1D1 UGT2A2 PON1 UGT2B10 DAO P4HA3 AASDH SCD5 TNXB PTGS2 ERLIN1 | 1.01e-06 | 1058 | 75 | 16 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | GALK1 MALRD1 BTD UGT2A1 ETFDH AKR1D1 UGT2A2 PON1 UGT2B10 DAO P4HA3 AASDH SCD5 TNXB PTGS2 ERLIN1 | 1.08e-06 | 1064 | 75 | 16 | GO:0006082 |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | GALK1 MALRD1 BTD UGT2A1 ETFDH AKR1D1 UGT2A2 UGT2B10 AASDH SCD5 TNXB PTGS2 ERLIN1 | 2.09e-06 | 731 | 75 | 13 | GO:0032787 |
| GeneOntologyBiologicalProcess | monoubiquitinated protein deubiquitination | 5.44e-06 | 10 | 75 | 3 | GO:0035520 | |
| GeneOntologyBiologicalProcess | esophagus smooth muscle contraction | 1.30e-05 | 2 | 75 | 2 | GO:0014846 | |
| GeneOntologyBiologicalProcess | bile acid metabolic process | 4.78e-05 | 55 | 75 | 4 | GO:0008206 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 5.86e-05 | 21 | 75 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.13e-04 | 26 | 75 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.13e-04 | 26 | 75 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP50 USP10 HECW1 MEGF8 USP9X USP40 USP7 TNKS KEAP1 AGBL5 USP9Y USP48 USP19 | 1.20e-04 | 1074 | 75 | 13 | GO:0043687 |
| GeneOntologyBiologicalProcess | positive regulation of vascular endothelial growth factor production | 2.12e-04 | 32 | 75 | 3 | GO:0010575 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP50 USP10 HECW1 MEGF8 USP9X USP40 USP7 TNKS KEAP1 USP9Y USP48 USP19 | 2.66e-04 | 1009 | 75 | 12 | GO:0070647 |
| Domain | USP_CS | 2.20e-10 | 66 | 75 | 8 | IPR018200 | |
| Domain | USP_1 | 3.56e-10 | 70 | 75 | 8 | PS00972 | |
| Domain | UCH | 4.00e-10 | 71 | 75 | 8 | PF00443 | |
| Domain | USP_2 | 4.00e-10 | 71 | 75 | 8 | PS00973 | |
| Domain | USP_3 | 4.49e-10 | 72 | 75 | 8 | PS50235 | |
| Domain | USP_dom | 4.49e-10 | 72 | 75 | 8 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 4.49e-10 | 72 | 75 | 8 | IPR001394 | |
| Domain | EGF_3 | 4.55e-06 | 235 | 75 | 8 | PS50026 | |
| Domain | EGF | 4.55e-06 | 235 | 75 | 8 | SM00181 | |
| Domain | EGF-like_dom | 6.97e-06 | 249 | 75 | 8 | IPR000742 | |
| Domain | EGF_1 | 8.29e-06 | 255 | 75 | 8 | PS00022 | |
| Domain | EGF-like_CS | 9.82e-06 | 261 | 75 | 8 | IPR013032 | |
| Domain | EGF_2 | 1.10e-05 | 265 | 75 | 8 | PS01186 | |
| Domain | EGF | 1.15e-05 | 126 | 75 | 6 | PF00008 | |
| Domain | Extracellular_sulfatase | 1.59e-05 | 2 | 75 | 2 | IPR014615 | |
| Domain | Extracellular_sulfatase_C | 1.59e-05 | 2 | 75 | 2 | IPR024609 | |
| Domain | DUF3740 | 1.59e-05 | 2 | 75 | 2 | PF12548 | |
| Domain | Growth_fac_rcpt_ | 3.86e-05 | 156 | 75 | 6 | IPR009030 | |
| Domain | EGF_extracell | 9.86e-05 | 60 | 75 | 4 | IPR013111 | |
| Domain | EGF_2 | 9.86e-05 | 60 | 75 | 4 | PF07974 | |
| Domain | PSI | 2.84e-04 | 32 | 75 | 3 | PF01437 | |
| Domain | Plexin_repeat | 2.84e-04 | 32 | 75 | 3 | IPR002165 | |
| Domain | PSI | 7.32e-04 | 44 | 75 | 3 | IPR016201 | |
| Domain | PSI | 8.34e-04 | 46 | 75 | 3 | SM00423 | |
| Domain | Kelch-typ_b-propeller | 1.40e-03 | 55 | 75 | 3 | IPR015915 | |
| Domain | - | 1.48e-03 | 56 | 75 | 3 | 3.50.50.60 | |
| Domain | VWA | 1.48e-03 | 56 | 75 | 3 | PF00092 | |
| Domain | FAD/NAD-binding_dom | 1.56e-03 | 57 | 75 | 3 | IPR023753 | |
| Domain | Gal_Oxase/kelch_b-propeller | 1.72e-03 | 59 | 75 | 3 | IPR011043 | |
| Domain | Sulfatase_CS | 1.84e-03 | 16 | 75 | 2 | IPR024607 | |
| Domain | SULFATASE_1 | 2.08e-03 | 17 | 75 | 2 | PS00523 | |
| Domain | SULFATASE_2 | 2.08e-03 | 17 | 75 | 2 | PS00149 | |
| Domain | Sulfatase | 2.34e-03 | 18 | 75 | 2 | PF00884 | |
| Domain | Sulfatase_N | 2.34e-03 | 18 | 75 | 2 | IPR000917 | |
| Domain | Fibrinogen_CS | 2.60e-03 | 19 | 75 | 2 | IPR020837 | |
| Domain | Kelch_1 | 2.81e-03 | 70 | 75 | 3 | PF01344 | |
| Domain | Kelch_1 | 2.81e-03 | 70 | 75 | 3 | IPR006652 | |
| Domain | - | 2.88e-03 | 20 | 75 | 2 | 4.10.70.10 | |
| Domain | UDPGT | 3.18e-03 | 21 | 75 | 2 | PF00201 | |
| Domain | Disintegrin | 3.18e-03 | 21 | 75 | 2 | PF00200 | |
| Domain | DISIN | 3.18e-03 | 21 | 75 | 2 | SM00050 | |
| Domain | UDPGT | 3.18e-03 | 21 | 75 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 3.18e-03 | 21 | 75 | 2 | IPR002213 | |
| Domain | Fibrinogen_a/b/g_C_2 | 4.15e-03 | 24 | 75 | 2 | IPR014715 | |
| Domain | - | 4.15e-03 | 24 | 75 | 2 | 4.10.530.10 | |
| Domain | MetalloPept_cat_dom | 4.24e-03 | 81 | 75 | 3 | IPR024079 | |
| Domain | - | 4.24e-03 | 81 | 75 | 3 | 3.40.390.10 | |
| Domain | VWFA | 4.39e-03 | 82 | 75 | 3 | PS50234 | |
| Domain | VWA | 4.69e-03 | 84 | 75 | 3 | SM00327 | |
| Domain | EGF_CA | 5.01e-03 | 86 | 75 | 3 | PF07645 | |
| Domain | DnaJ_domain_CS | 5.23e-03 | 27 | 75 | 2 | IPR018253 | |
| Domain | Fibrinogen_C | 5.23e-03 | 27 | 75 | 2 | PF00147 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 4.43e-07 | 191 | 52 | 8 | MM15289 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.34e-06 | 221 | 52 | 8 | M27578 | |
| Pathway | REACTOME_DEUBIQUITINATION | 4.74e-06 | 262 | 52 | 8 | MM15286 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.25e-05 | 299 | 52 | 8 | M27574 | |
| Pathway | REACTOME_GLUCURONIDATION | 9.07e-05 | 24 | 52 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.03e-04 | 25 | 52 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.03e-04 | 25 | 52 | 3 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 1.16e-04 | 26 | 52 | 3 | M39404 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.57e-04 | 258 | 52 | 6 | MM14572 | |
| Pathway | REACTOME_ASPIRIN_ADME | 5.64e-04 | 44 | 52 | 3 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 6.02e-04 | 45 | 52 | 3 | MM15694 | |
| Pathway | REACTOME_DRUG_ADME | 6.88e-04 | 109 | 52 | 4 | M45012 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.90e-04 | 300 | 52 | 6 | M610 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 9.21e-04 | 52 | 52 | 3 | M14171 | |
| Pathway | REACTOME_DRUG_ADME | 9.56e-04 | 119 | 52 | 4 | MM15692 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.08e-03 | 55 | 52 | 3 | M14933 | |
| Pubmed | A strategy for modulation of enzymes in the ubiquitin system. | 2.82e-10 | 17 | 77 | 5 | 23287719 | |
| Pubmed | Photocaged Cell-Permeable Ubiquitin Probe for Temporal Profiling of Deubiquitinating Enzymes. | 6.54e-09 | 64 | 77 | 6 | 33141564 | |
| Pubmed | 2.75e-08 | 81 | 77 | 6 | 12838346 | ||
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 2.98e-08 | 15 | 77 | 4 | 9827704 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MST1R ATRN CLPTM1L FAT1 SULF2 MEGF8 BTD P4HA3 ITGA1 USP48 ADAM10 PTGFRN ADAM22 ERLIN1 USP19 | 5.15e-08 | 1201 | 77 | 15 | 35696571 |
| Pubmed | 1.08e-07 | 257 | 77 | 8 | 16335952 | ||
| Pubmed | 3.63e-07 | 7 | 77 | 3 | 35163710 | ||
| Pubmed | 9.53e-07 | 147 | 77 | 6 | 29576527 | ||
| Pubmed | Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. | 4.84e-06 | 2 | 77 | 2 | 16901266 | |
| Pubmed | HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. | 4.84e-06 | 2 | 77 | 2 | 16192265 | |
| Pubmed | Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality. | 4.84e-06 | 2 | 77 | 2 | 28657777 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25420483 | ||
| Pubmed | SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. | 4.84e-06 | 2 | 77 | 2 | 24726914 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 34967276 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20394677 | ||
| Pubmed | SULFs in human neoplasia: implication as progression and prognosis factors. | 4.84e-06 | 2 | 77 | 2 | 21599997 | |
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 4.84e-06 | 2 | 77 | 2 | 12895410 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 27294358 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19781342 | ||
| Pubmed | Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. | 4.84e-06 | 2 | 77 | 2 | 20479257 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26448642 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 35131262 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 8922996 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 34489650 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17920055 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11439350 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12368295 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 37982895 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23418199 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 34324645 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18687675 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31461325 | ||
| Pubmed | Functional consequences of the subdomain organization of the sulfs. | 4.84e-06 | 2 | 77 | 2 | 19520866 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24625754 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23950901 | ||
| Pubmed | Ubiquitin-specific protease 9X in host cells interacts with herpes simplex virus 1 ICP0. | 4.84e-06 | 2 | 77 | 2 | 26596467 | |
| Pubmed | Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection. | 4.84e-06 | 2 | 77 | 2 | 23480519 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18507859 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12925892 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26764203 | ||
| Pubmed | SULF1/SULF2 reactivation during liver damage and tumour growth. | 4.84e-06 | 2 | 77 | 2 | 27013228 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31434553 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29360432 | ||
| Pubmed | The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. | 4.84e-06 | 2 | 77 | 2 | 35039640 | |
| Pubmed | Enhanced tumorigenic potential of colorectal cancer cells by extracellular sulfatases. | 4.84e-06 | 2 | 77 | 2 | 25477293 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22298771 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11376859 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 32038163 | ||
| Pubmed | Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. | 4.84e-06 | 2 | 77 | 2 | 10359671 | |
| Pubmed | 5.72e-06 | 16 | 77 | 3 | 36484700 | ||
| Pubmed | WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier. | 1.45e-05 | 3 | 77 | 2 | 21719793 | |
| Pubmed | Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. | 1.45e-05 | 3 | 77 | 2 | 17116694 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 31981475 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 22865881 | ||
| Pubmed | A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. | 1.45e-05 | 3 | 77 | 2 | 21455491 | |
| Pubmed | Desulfation of Heparan Sulfate by Sulf1 and Sulf2 Is Required for Corticospinal Tract Formation. | 1.45e-05 | 3 | 77 | 2 | 29062064 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 25448158 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 12177064 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 23756265 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 33495715 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 25370455 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 36279435 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 19858781 | ||
| Pubmed | 1.56e-05 | 22 | 77 | 3 | 34799561 | ||
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 1.79e-05 | 23 | 77 | 3 | 14715245 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 36183834 | ||
| Pubmed | Both G3BP1 and G3BP2 contribute to stress granule formation. | 2.89e-05 | 4 | 77 | 2 | 23279204 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 23074159 | ||
| Pubmed | Stress granules inhibit apoptosis by reducing reactive oxygen species production. | 2.89e-05 | 4 | 77 | 2 | 23230274 | |
| Pubmed | USP10 Inhibits Aberrant Cytoplasmic Aggregation of TDP-43 by Promoting Stress Granule Clearance. | 2.89e-05 | 4 | 77 | 2 | 35007165 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 35947662 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 23457216 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 20855470 | ||
| Pubmed | Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes. | 2.89e-05 | 4 | 77 | 2 | 23289620 | |
| Pubmed | Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. | 2.89e-05 | 4 | 77 | 2 | 17593974 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 33095475 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 35926709 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 24998844 | ||
| Pubmed | 2.94e-05 | 79 | 77 | 4 | 27325702 | ||
| Pubmed | 4.30e-05 | 87 | 77 | 4 | 24169447 | ||
| Pubmed | α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis. | 4.82e-05 | 5 | 77 | 2 | 30033122 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 22351753 | ||
| Pubmed | Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. | 4.82e-05 | 5 | 77 | 2 | 16141793 | |
| Pubmed | PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359. | 4.82e-05 | 5 | 77 | 2 | 30067985 | |
| Pubmed | USP10 regulates p53 localization and stability by deubiquitinating p53. | 4.82e-05 | 5 | 77 | 2 | 20096447 | |
| Pubmed | The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis. | 4.82e-05 | 5 | 77 | 2 | 31748695 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 18410486 | ||
| Pubmed | Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. | 4.82e-05 | 5 | 77 | 2 | 15039125 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 26235645 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 20643830 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 31771591 | ||
| Pubmed | 4.94e-05 | 32 | 77 | 3 | 33669244 | ||
| Pubmed | G3BP1 inhibits ubiquitinated protein aggregations induced by p62 and USP10. | 7.22e-05 | 6 | 77 | 2 | 31501480 | |
| Pubmed | Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer. | 7.22e-05 | 6 | 77 | 2 | 31833203 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 35636624 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 7.38e-05 | 1005 | 77 | 10 | 19615732 | |
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 24270891 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 18213582 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 20410206 | ||
| Pubmed | Competing Protein-RNA Interaction Networks Control Multiphase Intracellular Organization. | 1.01e-04 | 7 | 77 | 2 | 32302570 | |
| Cytoband | 9q33.2 | 2.03e-03 | 39 | 78 | 2 | 9q33.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.39e-03 | 797 | 78 | 6 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.47e-03 | 157 | 78 | 3 | chr4q13 | |
| GeneFamily | Ubiquitin specific peptidases | 4.69e-12 | 56 | 54 | 8 | 366 | |
| GeneFamily | UDP glucuronosyltransferases | 1.17e-04 | 32 | 54 | 3 | 363 | |
| GeneFamily | Sulfatases | 1.30e-03 | 18 | 54 | 2 | 410 | |
| GeneFamily | Fibrinogen C domain containing | 2.51e-03 | 25 | 54 | 2 | 554 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.93e-03 | 27 | 54 | 2 | 47 | |
| Coexpression | NABA_MATRISOME | NDNF C1QTNF8 ANGPTL6 SULF2 VWF MEGF8 SULF1 P4HA3 PAPPA ADAM10 TNXB ADAM22 SVEP1 | 8.44e-06 | 1026 | 77 | 13 | M5889 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | MST1R ATRN NDNF FAT1 SULF2 VWF SULF1 BTD P4HA3 PAPPA CFAP61 PTGFRN ADAM22 SVEP1 SMAD9 | 9.75e-06 | 1166 | 74 | 15 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.12e-07 | 162 | 78 | 6 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.83e-07 | 188 | 78 | 6 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 192 | 78 | 6 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 192 | 78 | 6 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 192 | 78 | 6 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 193 | 78 | 6 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 193 | 78 | 6 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-06 | 200 | 78 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.37e-05 | 174 | 78 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-05 | 180 | 78 | 5 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-05 | 181 | 78 | 5 | 8fd64404e57c22c204d835fc5626f73554257b19 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.84e-05 | 185 | 78 | 5 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.94e-05 | 187 | 78 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-05 | 187 | 78 | 5 | 0d4b7da81036c2aa678654b9fe49c939d08fcd9b | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-05 | 191 | 78 | 5 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-05 | 192 | 78 | 5 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 192 | 78 | 5 | 5388f3115ab285f3f3001af1d71543ed64b9e044 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-05 | 192 | 78 | 5 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 193 | 78 | 5 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 193 | 78 | 5 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.26e-05 | 193 | 78 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 193 | 78 | 5 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.26e-05 | 193 | 78 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 193 | 78 | 5 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.26e-05 | 193 | 78 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 2.32e-05 | 194 | 78 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 194 | 78 | 5 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.37e-05 | 195 | 78 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.43e-05 | 196 | 78 | 5 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.49e-05 | 197 | 78 | 5 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 2.55e-05 | 198 | 78 | 5 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-05 | 199 | 78 | 5 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 138 | 78 | 4 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.33e-04 | 148 | 78 | 4 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-04 | 58 | 78 | 3 | ee9038695d11a428dc222962721bfdf11dd6954f | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 157 | 78 | 4 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-04 | 160 | 78 | 4 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 161 | 78 | 4 | 176a4a72bb4892932da3c834d1fea5e211847f92 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.88e-04 | 162 | 78 | 4 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.88e-04 | 162 | 78 | 4 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 167 | 78 | 4 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 167 | 78 | 4 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 167 | 78 | 4 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-04 | 169 | 78 | 4 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 170 | 78 | 4 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 170 | 78 | 4 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.36e-04 | 172 | 78 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.36e-04 | 172 | 78 | 4 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.36e-04 | 172 | 78 | 4 | 5d654dd030ed22a701e15c5f09002951d99a52e8 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.41e-04 | 173 | 78 | 4 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.41e-04 | 173 | 78 | 4 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-04 | 174 | 78 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.52e-04 | 175 | 78 | 4 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-04 | 177 | 78 | 4 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-04 | 177 | 78 | 4 | fdf2af00fc971f0cd3915e1416e4a256458d6ea8 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.63e-04 | 177 | 78 | 4 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-04 | 177 | 78 | 4 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 177 | 78 | 4 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-04 | 177 | 78 | 4 | 12f8627124acbf436e75681ff1ce429ff5e3f256 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 2.69e-04 | 178 | 78 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.69e-04 | 178 | 78 | 4 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 179 | 78 | 4 | 9d7e39357b269d30ff1e8007a91f8645f3d80e73 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 179 | 78 | 4 | 1611e11f5f74432627e2f57a27e352b1e46be618 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-04 | 179 | 78 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.75e-04 | 179 | 78 | 4 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-04 | 180 | 78 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 180 | 78 | 4 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 180 | 78 | 4 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 180 | 78 | 4 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 180 | 78 | 4 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.87e-04 | 181 | 78 | 4 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-04 | 182 | 78 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-04 | 183 | 78 | 4 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-04 | 183 | 78 | 4 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-04 | 183 | 78 | 4 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.99e-04 | 183 | 78 | 4 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-04 | 183 | 78 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 184 | 78 | 4 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 78 | 4 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.11e-04 | 185 | 78 | 4 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.11e-04 | 185 | 78 | 4 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.11e-04 | 185 | 78 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 78 | 4 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 185 | 78 | 4 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.11e-04 | 185 | 78 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-04 | 186 | 78 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-04 | 186 | 78 | 4 | ed0a91f47e77fe21d4c7678d0f2a7c5f97d63dda | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-04 | 187 | 78 | 4 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 187 | 78 | 4 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.24e-04 | 187 | 78 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 187 | 78 | 4 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-04 | 187 | 78 | 4 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.24e-04 | 187 | 78 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.24e-04 | 187 | 78 | 4 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.24e-04 | 187 | 78 | 4 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-04 | 188 | 78 | 4 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.31e-04 | 188 | 78 | 4 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 188 | 78 | 4 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| Disease | Abnormality of the sense of smell, COVID-19 symptoms measurement, ageusia | 6.55e-06 | 2 | 76 | 2 | EFO_0600019, EFO_1001758, HP_0004408 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 7.70e-05 | 274 | 76 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | high density lipoprotein particle size measurement | 7.94e-05 | 170 | 76 | 5 | EFO_0008592 | |
| Disease | Cardiovascular Diseases | 1.10e-04 | 36 | 76 | 3 | C0007222 | |
| Disease | myocardial infarction (is_implicated_in) | 1.27e-04 | 99 | 76 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | Metabolic Diseases | 2.91e-04 | 10 | 76 | 2 | C0025517 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 3.13e-04 | 51 | 76 | 3 | EFO_0022285 | |
| Disease | Bipolar I disorder | 3.55e-04 | 11 | 76 | 2 | C0853193 | |
| Disease | Amyotrophic Lateral Sclerosis | 4.58e-04 | 58 | 76 | 3 | C0002736 | |
| Disease | Coronary Arteriosclerosis | 6.39e-04 | 65 | 76 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 6.39e-04 | 65 | 76 | 3 | C1956346 | |
| Disease | total lipids in very large HDL measurement | 6.69e-04 | 66 | 76 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 6.69e-04 | 66 | 76 | 3 | EFO_0022298 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 6.73e-04 | 15 | 76 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | cholesterol in very large HDL measurement | 7.61e-04 | 69 | 76 | 3 | EFO_0022229 | |
| Disease | atherosclerosis (is_implicated_in) | 7.67e-04 | 16 | 76 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | Endometrioma | 8.07e-04 | 161 | 76 | 4 | C0269102 | |
| Disease | Endometriosis | 8.07e-04 | 161 | 76 | 4 | C0014175 | |
| Disease | bipolar disorder (is_marker_for) | 1.09e-03 | 19 | 76 | 2 | DOID:3312 (is_marker_for) | |
| Disease | carotid artery disease (is_marker_for) | 1.09e-03 | 19 | 76 | 2 | DOID:3407 (is_marker_for) | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.13e-03 | 303 | 76 | 5 | EFO_0004612, EFO_0020945 | |
| Disease | free cholesterol in large HDL measurement | 1.13e-03 | 79 | 76 | 3 | EFO_0022157 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.19e-03 | 307 | 76 | 5 | EFO_0004612, EFO_0020946 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.28e-03 | 312 | 76 | 5 | EFO_0004612, EFO_0010351 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.34e-03 | 315 | 76 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.34e-03 | 315 | 76 | 5 | EFO_0004574, EFO_0004612 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.45e-03 | 321 | 76 | 5 | EFO_0004612, EFO_0004639 | |
| Disease | reticulocyte measurement | 1.52e-03 | 1053 | 76 | 9 | EFO_0010700 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.64e-03 | 330 | 76 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 1.74e-03 | 24 | 76 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 1.92e-03 | 95 | 76 | 3 | C0279626 | |
| Disease | cataract (is_implicated_in) | 2.04e-03 | 26 | 76 | 2 | DOID:83 (is_implicated_in) | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 2.37e-03 | 28 | 76 | 2 | DOID:0050866 (is_implicated_in) | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 2.54e-03 | 29 | 76 | 2 | DOID:332 (is_marker_for) | |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 2.54e-03 | 29 | 76 | 2 | C0393554 | |
| Disease | 1,5 anhydroglucitol measurement | 2.54e-03 | 29 | 76 | 2 | EFO_0008009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TIIYFHGNAGNIGHR | 116 | Q7L211 | |
| GVAYYVDLHGHASKR | 426 | Q8NDL9 | |
| YISGRVLEAGGKHYH | 216 | O94929 | |
| QGGILPGSYHYLHIA | 1041 | Q8NHU2 | |
| HIDGAYIYQNEHEVG | 51 | P51857 | |
| HIYTGHIYGEEGSFS | 101 | O14672 | |
| HKIEEGHLAVYYRGG | 26 | O75477 | |
| TVEVKGGEHCYYQGH | 126 | Q9P0K1 | |
| GLHGMFYDGNHTYLI | 156 | Q9P0K1 | |
| HGLPTEGYQALYHAV | 206 | O95567 | |
| TGLIYIGSHDQHAYA | 866 | Q4L235 | |
| HYYLSGVHGSSVAAE | 411 | O60423 | |
| HAYSVTGLQDVHYRG | 296 | Q9UMQ6 | |
| VGEELAYHYARLGSH | 41 | Q7Z5J1 | |
| NQDHYAVLGLGHVRY | 86 | Q99543 | |
| VTYEGHYSHTGQDGQ | 261 | Q5T481 | |
| LQVVNYGIGGHYEPH | 426 | Q7Z4N8 | |
| SNTEVIHNYGHGGYG | 301 | P14920 | |
| SGIYGHVTYHIVNDF | 2521 | Q14517 | |
| HYVHGICIYGNGDLK | 341 | Q8N0V5 | |
| RNNTEYRGGYHDGHL | 1496 | Q76N89 | |
| LVQGGYGHSSVYDHR | 496 | O75882 | |
| KHQRFGYVQHYGLGS | 246 | Q9BT17 | |
| VGRQVSHHYGYGLLD | 421 | Q6UW60 | |
| SHHYGYGLLDAGLLV | 426 | Q6UW60 | |
| RHIQEHYGGTATFYL | 366 | P51570 | |
| LGNYMVVYGGNVHTH | 456 | Q7Z7M0 | |
| YLLDVYVIGHGGHSV | 541 | Q8TB73 | |
| GHGVDLNHIYGETLA | 211 | P35354 | |
| FHDTLHVSGVYNGAG | 36 | Q32M88 | |
| GGSALNHNYRGYIEH | 241 | Q13219 | |
| EDDHGGAVYIYHGSG | 596 | P56199 | |
| GSGQLHYSVYEEARH | 26 | Q9Y5I2 | |
| FHYHMYGNGIGALTL | 1386 | Q5VYJ5 | |
| QHGSLGIYLYDHFGE | 96 | Q8N7S2 | |
| RHTYGGSFLYHLNEG | 301 | Q16134 | |
| GHGAQLLETVHRYYT | 251 | O14929 | |
| HRFYGKNSSYVHGGL | 31 | Q13283 | |
| LLAYGHHNQGVGYCQ | 141 | Q5TC63 | |
| GVFDGLHTVHGTYYI | 441 | P43251 | |
| DHYRLRLGQYHGDAG | 371 | Q8NI99 | |
| YGEHGDLYITFSGHL | 231 | P60827 | |
| HHVSVGGLGDSFYEY | 381 | Q9NR34 | |
| VHQGRIYVLGGYDGH | 561 | Q14145 | |
| HPGLGYEQRYHSGDV | 206 | Q9P2B2 | |
| HSGQASGGHYYSYII | 1871 | Q93008 | |
| VAVGPEHFYGTNDHY | 171 | P27169 | |
| YRTHLVAGIGFYQHL | 111 | Q9UPR3 | |
| AHGDFYVGDAYLVLH | 36 | Q9Y6U3 | |
| YLVHLNDHGELGYQG | 101 | P0DPQ3 | |
| LVALGAIGEGFHNYH | 261 | Q86SK9 | |
| DGTSVLHYDVHNLYG | 1446 | P14410 | |
| HVENAIARGVHYQYG | 3421 | Q4LDE5 | |
| HIGKGVHLYYVGGEV | 331 | O15198 | |
| EALSLGEVAYHDYHG | 261 | P35611 | |
| GEVAYHDYHGILVDE | 266 | P35611 | |
| SHGQEISGYIDYAHR | 121 | Q6V702 | |
| NGTLYAYIFLHHAGV | 101 | Q96KA5 | |
| ASHYLYVRAHGVRQG | 36 | Q9Y3A4 | |
| DGYVAHLGQLEAGSH | 1161 | O00562 | |
| LYAVINHYGGMIGGH | 1151 | O94966 | |
| VAVVEYHDGSHAYIG | 1316 | P04275 | |
| SYGHYEVAELLVRHG | 726 | O95271 | |
| HYANLNGLYGSTVDH | 4196 | P22105 | |
| VVNHFGDLDGGHYTA | 316 | Q70EL3 | |
| LVHSGQASGGHYYSY | 1871 | O00507 | |
| QDLGHGLRLIHYSYG | 56 | A0A0K0K1A3 | |
| NVGSGGAHASYYHRA | 211 | Q969M1 | |
| AVVYHHGNSATGGHY | 736 | Q14694 | |
| ITHGGANGIYEAIYH | 371 | P36537 | |
| YTHHGRQYLAQEGVI | 236 | Q16401 | |
| GRGYGYRVHHDVVAG | 276 | Q7RTT9 | |
| VLIHRGVSAYSGHYI | 341 | Q86UV5 | |
| GVSAYSGHYIAHVKD | 346 | Q86UV5 | |
| IIYTADHGYHIGQFG | 311 | Q8IWU6 | |
| GTSGHDLIYRLYHGT | 151 | Q9NVE5 | |
| THGGTNGIYEAIYHG | 371 | P0DTE4 | |
| HSGDNHGGHYVVYLN | 456 | Q93009 | |
| GHFGVVYHGEYIDQA | 1091 | Q04912 | |
| ADHGYHIGQFGLVKG | 316 | Q8IWU5 | |
| HGGTNGIYEAIYHGV | 381 | P0DTE5 | |
| VIHHYAGKVSYDVSG | 501 | O00160 |